Smoking-pill suicides overlooked

June 18, 2011February 28, 2022 ~ Jason Schwartz

Hundreds of reports of suicides, psychotic reactions and other serious problems tied to the popular stop-smoking drug Chantix were left out of a crucial government safety review because Pfizer Inc., the drug’s manufacturer, submitted years of data through “improper channels.”

Some 150 suicides — more than doubling those previously known — were among 589 delayed reports of severe issues turned up in a new analysis by the non-profit Institute for Safe Medication Practices.

Published by Jason Schwartz

I have been an addiction professional and social worker since 1994. I started blogging in 2005 as the Clinical Director at Dawn Farm. I currently serve as the Director of Social Work and Spiritual Care for a healthcare system. I've also served as the Director of Behavioral Health at another hospital. I'm also a lecturer at Eastern Michigan University’s School of Social Work. Views expressed here are my own. Keep in mind that the field, the contexts in which the field operates, and my views have changed over time. View all posts by Jason Schwartz

3 thoughts on “Smoking-pill suicides overlooked”

Tammy Hardin says:

June 18, 2011 at 10:41 pm

This kind of news doesn’t sell drugs. Unfortanetly we see all too much of the realities of these so called drugs that are supposed to help you in the rooms…

LikeLike
Charmie says:

June 19, 2011 at 12:05 am

This woman can explain the situation pretty well, she’s a whistle blower, spent something like 15 years as a sales rep for Bristol Meyers Squibb or however that’s spelled. She’s amazing
http://www.gwenolsen.com/

LikeLike
1. Jason Schwartz says:
  
  June 19, 2011 at 9:56 pm
  
  Hi Charmie!
  
  LikeLike